This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Jeet will be a trusted partner in cardiovascular care
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Subscribe To Our Newsletter & Stay Updated
